Literature DB >> 17981781

Mitochondria in multiple sclerosis.

Pedram Ghafourifar1, Kazem Mousavizadeh, Mordhwaj S Parihar, Rafal R Nazarewicz, Arti Parihar, Woineshet J Zenebe.   

Abstract

Multiple sclerosis (MS) is a neurological disorder of the central nervous system characterized by demyelination and neurodegeneration. Although the pathogenesis of MS is not completely understood, various studies suggest that immune-mediated loss of myelin and mitochondrial dysfunction are associated with the disease. Mitochondria are one of the main cellular sources of reactive oxygen species (ROS) and reactive nitrogen species (RNS) and play a pivotal role in many neuro-pathological conditions. Mitochondrial dysfunction leading to excessive production of ROS and RNS plays a significant role in the pathogenesis of MS, particularly in loss of myelin/oligodendrocyte complex. The present review summarizes critical role of mitochondria in the pathogenesis of MS. Further understanding of the role of mitochondria in MS may provide rationale for novel approaches to this disease and development of novel therapeutic maneuvers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981781     DOI: 10.2741/2913

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  21 in total

1.  Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.

Authors:  M Bonora; E De Marchi; S Patergnani; J M Suski; F Celsi; A Bononi; C Giorgi; S Marchi; A Rimessi; J Duszyński; T Pozzan; M R Wieckowski; P Pinton
Journal:  Cell Death Differ       Date:  2014-03-21       Impact factor: 15.828

Review 2.  NADPH oxidases as therapeutic targets in ischemic stroke.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

3.  Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration.

Authors:  Sean R Werner; Joy K Saha; Carol L Broderick; Eugene Y Zhen; Richard E Higgs; Kevin L Duffin; Rosamund C Smith
Journal:  J Mol Neurosci       Date:  2010-04-17       Impact factor: 3.444

Review 4.  Oxidative Stress and Neurobiology of Demyelination.

Authors:  Srdjan Ljubisavljevic
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

5.  Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis.

Authors:  Fucheng Luo; Karl Herrup; Xin Qi; Yan Yang
Journal:  Exp Neurol       Date:  2017-02-24       Impact factor: 5.330

6.  Oxidant regulated inter-subunit disulfide bond formation between ASIC1a subunits.

Authors:  Xiang-ming Zha; Runping Wang; Dan M Collier; Peter M Snyder; John A Wemmie; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

7.  Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements.

Authors:  Garth L Nicolson
Journal:  Integr Med (Encinitas)       Date:  2014-08

8.  MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.

Authors:  Milena Stosic; Julian Ambrus; Neeta Garg; Bianca Weinstock-Guttman; Murali Ramanathan; Bernadette Kalman; Alireza Minagar; Frederick E Munschauer; Timothy M Galey; Sara Hussein; Rohit Bakshi; Robert Zivadinov
Journal:  J Neurol       Date:  2009-07-26       Impact factor: 4.849

9.  SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle.

Authors:  Claudia Figueroa-Romero; Jorge A Iñiguez-Lluhí; Julia Stadler; Chuang-Rung Chang; Damien Arnoult; Peter J Keller; Yu Hong; Craig Blackstone; Eva L Feldman
Journal:  FASEB J       Date:  2009-07-28       Impact factor: 5.191

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.